Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#2 Victoria VR Victoria VR +11.02%
#3 Palladium Network Palladium Network +8.55%
#4 Cryptopia Cryptopia +4.36%
#5 COTI COTI +3.80%
#6 GRVT Token GRVT Token +2.92%
#7 Lisk Lisk +2.64%
#8 NEAR Intents Bridged ZEC NEAR Intents Bridged ZEC +2.61%
#9 Kinetiq Kinetiq +2.57%
#10 Lighter Lighter +2.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Rankning i aktier #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-07-02
Marknadsvärde
$2.20K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
CA
Handel Cotinga Pharmaceuticals Inc. (COTQF)

Kategori

Healthcare
Aktiekurshistorik för Cotinga Pharmaceuticals Inc. (COTQF)
Högsta slutkurs: $0.00 den 2026-07-01

Lägsta slutkurs: $0.42 den 2009-09-01
Aktiekurshistorik för Cotinga Pharmaceuticals Inc. från 2009 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 900.00%
2021 -99.99%
2020 3,089.48%
2019 12.40%
2018 -95.52%
2017 -73.25%
2016 53.81%
2015 3.50%
2014 33.09%
2013 16.94%
2012 -61.29%
2011 145.58%
2010 -65.69%
2009 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.57%
KR